Federal Register / Vol. 77, No. 61 / Thursday, March 29, 2012 / Notices 19017 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

NCEH/ATSDR Exposure 

Investigations (EIs) [OMB NO: 0923– 

0040, Expiration Date 11/30/2012]— 

Revision—The National Center for 

Environmental Health (NCEH), and the 

Agency for Toxic Substances and 

Disease Registry (ATSDR), and the 

Centers for Disease Control and 

Prevention (CDC). 

Background and Brief Description 

This is a brief summary of a joint 

clearance between the NCEH and 

ATSDR, (hereafter ATSDR will 

represent both ATSDR and NCEH). 

ATSDR is mandated pursuant to the 

1980 Comprehensive Environmental 

Response, Compensation, and Liability 

Act (CERCLA) and its 1986 

Amendments, the Superfund 

Amendments and Reauthorization Act 

(SARA) to prevent or mitigate adverse 

human health effects and diminished 

quality of life resulting from the 

exposure to hazardous substances in the 

environment. EIs are an approach 

developed by ATSDR that employs 

targeted biologic (e.g., urine, blood, hair 

samples) and environmental (e.g., air, 

water, soil, or food) sampling to 

determine whether people are or have 

been exposed to unusual levels of 

pollutants at specific locations (e.g., 

where people live, spend leisure time, 

or anywhere they might come into 

contact with contaminants under 

investigation). After a chemical release 

or suspected release into the 

environment, ATSDR’s EIs are used by 

public health professionals, 

environmental risk managers, and other 

decision makers to determine if current 

conditions warrant intervention 

strategies to minimize or eliminate 

human exposure. EIs are usually 

requested by officials of a state health 

agency, county health departments, the 

Environmental Protection Agency, the 

general public, and ATSDR staff. 

ATSDR has been conducting EIs since 

1995 throughout the United States. All 

of ATSDR’s biomedical assessments and 

some of the environmental 

investigations involve participants. 

Participation is completely voluntary. 

To assist in interpreting the sampling 

results, a survey questionnaire 

appropriate to the specific contaminant 

is administered to participants. ATSDR 

collects contact information (e.g., name, 

address, phone number) to provide the 

participant with their individual results. 

Name and address information are 

broken into nine separate questions 

(data fields) for computer entry. General 

information, which includes height, 

weight, age, race, gender, etc., is also 

collected primarily on biomedical 

investigations to assist with results 

interpretation. General information can 

account for approximately 20 questions 

per investigation. Some of this 

information is investigation-specific; not 

all of this data is collected for every 

investigation. ATSDR is seeking a 

revision of our approval for use of a set 

of 61 general information questions. 

ATSDR also collects information on 

other possible confounding sources of 

chemical(s) exposure such as medicines 

taken, foods eaten, hobbies, jobs, etc. In 

addition, ATSDR asks questions on 

recreational or occupational activities 

that could increase a participant’s 

exposure potential. That information 

represents an individual’s exposure 

history. To cover those broad categories, 

ATSDR is also seeking a revision to our 

approval for the use of sets of topical 

questions. Of these, we use 

approximately 12–20 questions about 

the pertinent environmental exposures 

per investigation. This number can vary 

depending on the number of chemicals 

being investigated, the route of exposure 

(e.g., breathing, eating, touching), and 

number of other sources of the 

chemical(s) (e.g., products used, jobs). 

Typically, the number of participants 

in an individual EI ranges from 10 to 

100. Questionnaires are generally 

needed in less than half of the EIs 

(approximately 7 per year). 

The subject matter for the complete 

set of topical questions includes the 

following: 

(1) Media specific which includes: Air 

(indoor/outdoor); water (water source 

and plumbing); soil, and food 

(gardening, fish, game, domestic 

animals (e.g., chickens). 

(2) Other sources such as: 

occupations; hobbies; household 

chemical uses and house construction 

characteristics; lifestyle (e.g., smoking); 

medicines and/or health conditions, and 

foods. There are no costs to respondents 

other than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Respondents Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

Exposure Investigation Participants ................................................................ 700 1 30/60 350 

Dated: March 23, 2012. 

Ron A. Otten, 

Director, Office of Scientific Integrity, Office 

of the Associate Director for Science (OADS), 

Office of the Director, Centers for Disease 

Control and Prevention. 

[FR Doc. 2012–7531 Filed 3–28–12; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Board on Radiation and 

Worker Health (ABRWH or Advisory 

Board), National Institute for 

Occupational Safety and Health 

(NIOSH) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC), 

announces the following meeting of the 

aforementioned committee: 

Time and Date: 11 a.m.–3 p.m., April 26, 

2012. 

Place: Audio Conference Call via FTS 

Conferencing. The USA toll-free, dial-in 

number is 1 (866) 659–0537 and the pass 

code is 9933701. 

Status: Open to the public, but without a 

verbal public comment period. Written 

comment should be provided to the contact 

person below in advance of the meeting. 

Background: The Advisory Board was 

established under the Energy Employees 

Occupational Illness Compensation Program 

mstockstill on DSK4VPTVN1PROD with NOTICES

19018 Federal Register / Vol. 77, No. 61 / Thursday, March 29, 2012 / Notices 

Act of 2000 to advise the President on a 

variety of policy and technical functions 

required to implement and effectively 

manage the new compensation program. Key 

functions of the Advisory Board include 

providing advice on the development of 

probability of causation guidelines, which 

have been promulgated by the Department of 

Health and Human Services (HHS) as a final 

rule; advice on methods of dose 

reconstruction, which have also been 

promulgated by HHS as a final rule; advice 

on the scientific validity and quality of dose 

estimation and reconstruction efforts being 

performed for purposes of the compensation 

program; and advice on petitions to add 

classes of workers to the Special Exposure 

Cohort (SEC). 

In December 2000, the President delegated 

responsibility for funding, staffing, and 

operating the Advisory Board to HHS, which 

subsequently delegated this authority to the 

CDC. NIOSH implements this responsibility 

for CDC. The charter was issued on August 

3, 2001, renewed at appropriate intervals, 

most recently, August 3, 2011, and will 

expire on August 3, 2013. 

Purpose: This Advisory Board is charged 

with (a) providing advice to the Secretary, 

HHS, on the development of guidelines 

under Executive Order 13179; (b) providing 

advice to the Secretary, HHS, on the 

scientific validity and quality of dose 

reconstruction efforts performed for this 

program; and (c) upon request by the 

Secretary, HHS, advising the Secretary on 

whether there is a class of employees at any 

Department of Energy facility who were 

exposed to radiation but for whom it is not 

feasible to estimate their radiation dose, and 

on whether there is reasonable likelihood 

that such radiation doses may have 

endangered the health of members of this 

class. 

Matters To Be Discussed: The agenda for 

the conference call includes: SEC Petition for 

Feed Materials Production Center (Fernald, 

Ohio); Subcommittee and Work Group 

Updates; SEC Petition Evaluations Update for 

the June 2012 Advisory Board Meeting; and 

Board Correspondence. 

The agenda is subject to change as 

priorities dictate. 

Because there is not a verbal public 

comment period, written comments may be 

submitted. Any written comments received 

will be included in the official record of the 

meeting and should be submitted to the 

contact person below in advance of the 

meeting. 

Contact Person for More Information: 

Theodore M. Katz, M.P.A., Designated 

Federal Officer, NIOSH, CDC, 1600 Clifton 

Road NE., Mailstop: E–20, Atlanta, Georgia 

30333, Telephone (513)533–6800, Toll Free 

1(800) CDC–INFO, Email ocas@cdc.gov. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: March 22, 2012. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2012–7554 Filed 3–28–12; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee to the Director 

(ACD), Centers for Disease Control and 

Prevention (CDC) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the CDC announces 

the following meeting of the 

aforementioned committee. 

Time and Date: 8:30 a.m.–3 p.m. (EDT), 

April 26, 2012. 

Place: CDC, 1600 Clifton Road NE., 

Building 21, Rooms 1204 A/B, Atlanta, 

Georgia 30333. This meeting is also available 

by teleconference. Please dial (877) 930–8819 

and enter code 1579739. 

Status: Open to the public, limited only by 

the space available. The meeting room 

accommodates approximately 50 people. To 

accommodate public participation in the 

meeting, a conference telephone line will be 

available. The public is welcome to 

participate during the public comment 

period. The public comment period is 

tentatively scheduled from 2:45 p.m. until 

2:50 p.m. 

Purpose: The committee will provide 

advice to the CDC Director on strategic and 

other broad issues facing CDC. 

Matters To Be Discussed: The Advisory 

Committee to the Director will receive 

updates from the Global Workgroup; State, 

Tribal, Local and Territorial Workgroup; the 

Policy Workgroup; the Communications 

Workgroup; the Ethics Subcommittee, and 

the Health Disparities Subcommittee, as well 

as an update from the CDC Director. 

Agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: 

Carmen Villar, MSW, Designated Federal 

Officer, Advisory Committee to the Director, 

CDC, 1600 Clifton Road NE., M/S D–14, 

Atlanta, Georgia 30333, telephone 404/639– 

7000, email: GHickman@cdc.gov. The 

deadline for notification of attendance is 

April 20, 2012. To register for this meeting, 

please send an email to ACDirector@cdc.gov. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: March 23, 2012. 

Elizabeth Millington, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. 2012–7551 Filed 3–28–12; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Initial Review 

The meeting announced below 

concerns Conducting Public Health 

Research in South Africa, Funding 

Opportunity Announcement (FOA) 

GH12–004, initial review. 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time and Date: 12 p.m.–4 p.m., May 2, 

2012 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c) (4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters To Be Discussed: The meeting will 

include the initial review, discussion, and 

evaluation of applications received in 

response to ‘‘Conducting Public Health 

Research in South Africa, FOA GH12–004.’’ 

Contact Person for More Information: Lata 

Kumar, Scientific Review Officer, CGH 

Science Office, Center for Global Health, 

CDC, 1600 Clifton Road NE., Mailstop D–69, 

Atlanta, Georgia 30033, Telephone (404) 

639–7618. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: March 22, 2012. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2012–7545 Filed 3–28–12; 8:45 am] 

BILLING CODE 4163–18–P 

mstockstill on DSK4VPTVN1PROD with NOTICES